Johnson & Johnson to Hire 300 People to Make Possible COVID-19 Vaccine at Bloomington Plant

FROM LOCAL SOURCES / PHOTO: BUSINESS INSIDER 
BLOOMINGTON -- A subsidiary of Johnson & Johnson may have a vaccine for the coronavirus and plans to use a facility in Bloomington to help manufacture it. 

Johnson & Johnson says it's leading vaccine candidate for the COVID-19 virus is still in development and hopes to start conducting clinical trials in September. Until then, the company needs to make more of it and has partnered with Catalant, Inc. to do it. 

Catalant tells Inside Indiana Business it plans to add 300 jobs to it's facility in Bloomington in order to help start making the vaccine.